KDR gene mutations, insertions, and deletions are associated with cancer occurrence, and alterations are observed in 3.02% of all cancers including lung adenocarcinoma, melanoma, colon adenocarcinoma, and conventional glioblastoma (The AACR Project GENIE Consortium, 2017). This evidence concerns the gene KDR and cancer.